搜索优化
Rewards
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 7 天
时间不限
过去 1 小时
过去 24 小时
过去 30 天
按时间排序
按相关度排序
mskcc.org
10 小时
MSK Doctor Discusses Magnesium’s Health Benefits: What Cancer Patients Should Know
Learn about magnesium's essential role in overall health and in cancer treatment and prevention. Dr. Urvi Shah answers ...
Targeted Oncology
3 天
Approved Therapies Considered for Patients With Graft-Vs-Host Disease
Noah M. Merin, MD, PhD, assistant professor at Cedars-Sinai Medicine and medical director of the Hematology and Cellular ...
The American Journal of Managed Care
3 天
First Schizophrenia Treatment Approved in Decades Targets Cholinergic Receptors
Formally known as KarXT, xanomeline-trospium chloride (Cobenfy) receives approval from the FDA for the treatment of ...
The American Journal of Managed Care
3 天
FDA Approves Dupilumab as First Biologic Treatment for COPD
The FDA approved dupilumab today as the first biologic treatment for patients with uncontrolled chronic obstructive pulmonary ...
PipelineReview.com
3 天
Dupixent approved in the US as the first-ever biologic medicine for patients with COPD
PARIS, France and TARRYTOWN, NY, USA I7, 2024 I The US Food and Drug Administration (FDA) has approved Dupixent (dupilumab) as an add-on ...
3 天
Dupixent® (dupilumab) Approved in the U.S. as the First-ever Biologic Medicine for ...
Dupixent is indicated for the approximately 300,000 adults in the U.S. with inadequately controlled chronic obstructive pulmonary disease (COPD) ...
3 天
Press Release: Dupixent approved in China as the first-ever biologic medicine for patients ...
Dupixent approved in China as the first-ever biologic medicine for patients with COPDApproval follows EU approval of Dupixent for adults with ...
3 天
Dupixent® (dupilumab) Approved in China as the First-ever Biologic Medicine for Patients ...
Approval follows EU approval of Dupixent for adults with COPD with raised blood eosinophils, and is based on two landmark Phase 3 trials showing Dupixent significantly reduced exacerbations, improved ...
Health.com
4 天
How Often Do You Poop? New Research Shows Bowel Movement Frequency Linked to Overall Health
A new study found that the average frequency of your bowel movements could impact your microbiome and risk of chronic disease ...
4 天
The BRAT is a go-to for stomach bugs. But experts are recommending it less often — here's why
The BRAT diet has long been used to treat stomach bugs, but recent research shows it may not be as helpful as previously ...
5 天
Pfizer Voluntarily Withdraws All Lots of Sickle Cell Disease Treatment OXBRYTA® (voxelotor ...
Pfizer Inc. (NYSE: PFE) announced today that it is voluntarily withdrawing all lots of OXBRYTA® (voxelotor) for the treatment ...
TMCnet
6 天
Barinthus Bio Initiates Phase 1 Clinical Trial of VTP-1000 for the Treatment of Celiac Disease
VTP-1000 is an investigational, injectable antigen-specific tolerance immunotherapy that utilizes Barinthus Bio’s proprietary SNAP-TI platform to co-deliver multiple gluten-derived peptide antigens ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈